Epicin ® 50 mg Injection
(Epirubicin Hydrochloride 50mg)



GENERIC NAME: Epirubicin Hydrochloride 50mg
THERAPEUTIC CLASS: Antineoplastic Agent- Anthracyclines
INDICATIONS & DOSAGE:
- Breast Cancer (as an adjuvant therapy)
- Advanced ovarian cancer
- Soft tissue sarcoma
- Non-Hodgkin lymphoma
- Gastric cancer
STORAGE:Store between 15 °C and 30 °C. Protected from sunlight
PACK SIZE: 1×1’s
DOSAGE & ADMINISTRATION:
The recommended starting dose of Epirubicin is 100 to 120mg/m2 IV infusion for 15-20 minutes repeated 3 to 4 weeks cycle. The total dose of Epirubicin may be given on Day 1 of each cycle or divide equally and given on Days 1 and 8 of each cycle.
Special consideration should be given to administration of lower starting dose of Epirubicin in hepatic dysfunction, bone marrow dysfunction and renal dysfunction patients.